Status:
RECRUITING
An Iodine Balance Study to Investigate the Recommended Iodine Intake in an Elderly Population
Lead Sponsor:
Wenxing Guo
Collaborating Sponsors:
Tianjin Medical University General Hospital
Gansu Provincial Centre for Disease Control and Prevention
Conditions:
Nutrition, Healthy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Current Chinese dietary iodine reference intake (DRIs) standards lack direct data on recommended iodine intake (RNI) in the elderly. The elderly have a high prevalence of thyroid diseases. The risk th...
Detailed Description
The investigators measured subjects' food and water intake throughout the day using weighing methods, and collected all urine and fecal samples. Food, drinking water, fecal and urine samples were take...
Eligibility Criteria
Inclusion
- The target population of this study is elderly people over 60 years old. Adults living in the same household can also participate.
- aged 18 and above;
- at least 5 years of local residence.
Exclusion
- family genetic diseases；
- special dietary habits；
- taking iodine-containing drugs or supplements；
- metabolic diseases;
- thyroid diseases.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06218043
Start Date
April 1 2023
End Date
December 31 2025
Last Update
January 23 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Gansu provincial center for disease control and prevention
Lanzhou, Gansu, China, 730099
2
Shandong provincial institute for endemic disease control
Jinan, Shandong, China, 250014
3
Tianjin Medical University
Tianjin, Tianjin Municipality, China, 300070